The critical care clinical pharmacist: Evolution of an essential team member

被引:65
作者
Horn, E [1 ]
Jacobi, J
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[2] Methodist Hosp, Clarian Hlth Partners, Indianapolis, IN USA
关键词
critical care; pharmacy; intensive care; manpower; outcome;
D O I
10.1097/01.CCM.0000199990.68341.33
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To review the history, training requirements, contributions to patient care outcomes, and workforce issues of critical care pharmacists. Data Source and Selection: Literature obtained through Med-line search with manual cross-referencing. Data Extraction and Synthesis: Original and selected review articles and guideline documents were reviewed for references to critical care pharmacists and their role on the multiprofessional critical care team. Conclusions. Critical care pharmacists are recognized as essential members of the critical care team as a result of contributions to medication safety, improved patient outcomes, and reduced drug costs and as a source of drug information and provider of education. A growing number of pharmacists practice in critical care. Additional opportunities exist and can be met if an adequate supply of trained specialists can be developed.
引用
收藏
页码:S46 / S51
页数:6
相关论文
共 36 条
[1]  
[Anonymous], 2000, PHARM WORKF STUD SUP
[2]  
*ASHP, 1982, AM J HOSP PHARM, V39, P1967
[3]  
ASHP CommissiononCredentialinginconjunctionwiththe Specialty PracticeGrouponCriticalCarePharmacyPractice, 1990, AM J HOSP PHARM, V47, P609
[4]   Cost savings from having a clinical pharmacist work part-time in a medical intensive care unit [J].
Baldinger, SL ;
Chow, MSS ;
Cannon, RH ;
Kelly, ET .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (24) :2811-2814
[5]  
Bearce W C, 1988, Hosp Pharm, V23, P883
[6]   Evidence-based core clinical pharmacy services in United States hospitals in 2020: Services and staffing [J].
Bond, CA ;
Raehl, CL ;
Patry, R .
PHARMACOTHERAPY, 2004, 24 (04) :427-440
[7]   Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model [J].
Brilli, RJ ;
Spevetz, A ;
Branson, RD ;
Campbell, GM ;
Cohen, H ;
Dasta, JF ;
Harvey, MA ;
Kelley, MA ;
Kelly, KM ;
Rudis, MI ;
St Andre, AC ;
Stone, JR ;
Teres, D ;
Weled, BJ .
CRITICAL CARE MEDICINE, 2001, 29 (10) :2007-2019
[8]   DRUG UTILIZATION IN A GENERAL INTENSIVE-CARE UNIT [J].
BUCHANAN, N ;
CANE, RD .
INTENSIVE CARE MEDICINE, 1978, 4 (02) :75-77
[9]  
Chuang L C, 1994, Hosp Pharm, V29, P215
[10]   Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units [J].
Cullen, DJ ;
Sweitzer, BJ ;
Bates, DW ;
Burdick, E ;
Edmondson, A ;
Leape, LL .
CRITICAL CARE MEDICINE, 1997, 25 (08) :1289-1297